Clinical Trial Update: Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating pembrolizumab in combination with chemotherapy for newly diagnosed Primary Central Nervous System Lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma
• Lymphoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Lymphoma, Primary Central Nervous System Lymphoma | Phase 1 | Status: RECRUITING